A SINGLE ARM, OPEN-LABEL PILOT TRIAL OF THE SAFETY AND IMMUNOGENICITY OF A QUADR

Quadr 安全性和免疫原性的单臂、开放标签试点试验

• 批准号: 7951594
• 负责人: RONALD T. MITSUYASU
• 金额: $ 9.4万
• 依托单位: UNIVERSITY OF CALIFORNIA LOS ANGELES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-04-01 至 2009-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7951594
• 关键词: Antibodies; Clinical Research; Computer Retrieval of Information on Scientific Projects Database; Funding; Grant; Human Papilloma Virus Vaccine; Human Papillomavirus; Institution; Recombinant Vaccines; Research; Research Personnel; Resources; Safety; Source; United States National Institutes of Health; Upper arm; immunogenicity; men; open label; pilot trial

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. To assess the safety and tolerability of the quadrivalent HPV recombinant vaccine in HIV-infected men. To assess the immunogenicity of the quadrivalent HPV vaccine for types 6, 11, 16 and 18 in subjects who are antibody-negative at baseline.

该副本是利用众多研究子项目之一 由NIH/NCRR资助的中心赠款提供的资源。子弹和 调查员（PI）可能已经从其他NIH来源获得了主要资金， 因此可以在其他清晰的条目中代表。列出的机构是 对于中心，这不一定是调查员的机构。 评估艾滋病毒感染男性中二次HPV重组疫苗的安全性和耐受性。 为了评估基线抗体阴性受试者的6、11、16和18型四相HPV疫苗的免疫原性。